Literature DB >> 23820588

Striatal shape in Parkinson's disease.

Nicholas W Sterling1, Guangwei Du, Mechelle M Lewis, Christopher Dimaio, Lan Kong, Paul J Eslinger, Martin Styner, Xuemei Huang.   

Abstract

Parkinson's disease (PD) is marked pathologically by nigrostriatal dopaminergic terminal loss. Histopathological and in vivo labeling studies demonstrate that this loss occurs most extensively in the caudal putamen and caudate head. Previous structural studies have suggested reduced striatal volume and atrophy of the caudate head in PD subjects. The spatial distribution of atrophy in the putamen, however, has not been characterized. We aimed to delineate the specific locations of atrophy in both of these striatal structures. T1- and T2-weighted brain MR (3T) images were obtained from 40 PD and 40 control subjects having no dementia and similar age and gender distributions. Shape analysis was performed using doubly segmented regions of interest. Compared to controls, PD subjects had lower putamen (p = 0.0003) and caudate (p = 0.0003) volumes. Surface contraction magnitudes were greatest on the caudal putamen (p ≤ 0.005) and head and dorsal body of the caudate (p ≤ 0.005). This spatial distribution of striatal atrophy is consistent with the known pattern of dopamine depletion in PD and may reflect global consequences of known cellular remodeling phenomena.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caudate; Magnetic resonance imaging (MRI); Morphology; Parkinson's disease; Putamen; Shape; Striatum; Structure; Volume

Mesh:

Year:  2013        PMID: 23820588      PMCID: PMC3742686          DOI: 10.1016/j.neurobiolaging.2013.05.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  50 in total

Review 1.  The primate basal ganglia: parallel and integrative networks.

Authors:  Suzanne N Haber
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

2.  Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors.

Authors:  Martin Styner; Jeffrey A Lieberman; Robert K McClure; Daniel R Weinberger; Douglas W Jones; Guido Gerig
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

3.  Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease.

Authors:  T H McNeill; S A Brown; J A Rafols; I Shoulson
Journal:  Brain Res       Date:  1988-07-05       Impact factor: 3.252

4.  Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Authors:  B Stephens; A J Mueller; A F Shering; S H Hood; P Taggart; G W Arbuthnott; J E Bell; L Kilford; A E Kingsbury; S E Daniel; C A Ingham
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease.

Authors:  S Zaja-Milatovic; D Milatovic; A M Schantz; J Zhang; K S Montine; A Samii; A Y Deutch; T J Montine
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

7.  Subcortical brain atrophy persists even in HAART-regulated HIV disease.

Authors:  James T Becker; Joanne Sanders; Sarah K Madsen; Ann Ragin; Lawrence Kingsley; Victoria Maruca; Bruce Cohen; Karl Goodkin; Eileen Martin; Eric N Miller; Ned Sacktor; Jeffery R Alger; Peter B Barker; Priyanka Saharan; Owen T Carmichael; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2011-06       Impact factor: 3.978

Review 8.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Authors:  Maria C Rodriguez-Oroz; Marjan Jahanshahi; Paul Krack; Irene Litvan; Raúl Macias; Erwan Bezard; José A Obeso
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

9.  Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.

Authors:  M Otsuka; Y Ichiya; Y Kuwabara; S Hosokawa; M Sasaki; T Yoshida; T Fukumura; K Masuda; M Kato
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

10.  Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.

Authors:  Stefan Schuster; Evelyne Doudnikoff; Daniella Rylander; Amandine Berthet; Incarnation Aubert; Carina Ittrich; Bertrand Bloch; M Angela Cenci; D James Surmeier; Bastian Hengerer; Erwan Bezard
Journal:  Biol Psychiatry       Date:  2008-10-23       Impact factor: 13.382

View more
  27 in total

1.  Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.

Authors:  Jared J Tanner; Shellie-Anne Levy; Nadine A Schwab; Loren P Hizel; Peter T Nguyen; Michael S Okun; Catherine C Price
Journal:  Clin Neuropsychol       Date:  2016-11-04       Impact factor: 3.535

2.  Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.

Authors:  S Gazzina; E Premi; R Turrone; J Acosta-Cabronero; M C Rizzetti; M S Cotelli; R Gasparotti; A Padovani; B Borroni
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

3.  The role of the dorsal striatum in the recognition of emotions expressed by voice in Parkinson's disease.

Authors:  Sonia Di Tella; Isabella Anzuino; Federica Biassoni; Maria Rita Ciceri; Martina Gnerre; Raffaello Nemni; Monia Cabinio; Francesca Baglio; Maria Caterina Silveri
Journal:  Neurol Sci       Date:  2021-01-07       Impact factor: 3.307

4.  Predicting auditory feedback control of speech production from subregional shape of subcortical structures.

Authors:  Xiaoying Tang; Na Chen; Siyun Zhang; Jeffery A Jones; Baofeng Zhang; Jingyuan Li; Peng Liu; Hanjun Liu
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

5.  Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder.

Authors:  Shady Rahayel; Ronald B Postuma; Jacques Montplaisir; Daphné Génier Marchand; Frédérique Escudier; Malo Gaubert; Pierre-Alexandre Bourgouin; Julie Carrier; Oury Monchi; Sven Joubert; Frédéric Blanc; Jean-François Gagnon
Journal:  Neurology       Date:  2018-04-18       Impact factor: 9.910

Review 6.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

Review 7.  Structural Imaging in Parkinson's Disease: New Developments.

Authors:  Stéphane Prange; Elise Metereau; Stéphane Thobois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-18       Impact factor: 5.081

8.  Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Authors:  Anelya Kh Alieva; Elena V Filatova; Anna A Kolacheva; Margarita M Rudenok; Petr A Slominsky; Mikhail V Ugrumov; Maria I Shadrina
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

9.  Differentiating Patients with Parkinson's Disease from Normal Controls Using Gray Matter in the Cerebellum.

Authors:  Ling-Li Zeng; Liang Xie; Hui Shen; Zhiguo Luo; Peng Fang; Yanan Hou; Beisha Tang; Tao Wu; Dewen Hu
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

10.  Lexical-semantic search related to side of onset and putamen volume in Parkinson's disease.

Authors:  Daymond Wagner; Paul J Eslinger; Nicholas W Sterling; Guangwei Du; Eun-Young Lee; Martin Styner; Mechelle M Lewis; Xuemei Huang
Journal:  Brain Lang       Date:  2020-08-17       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.